Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome.
Dyshidrotic eczema is one of the rare cutaneous adverse effects of intravenous immunoglobulin therapy, usually seen in adults. We herein report the first pediatric case of severe dyshidrotic eczema occurring after intravenous immunoglobulin therapy for Kawasaki syndrome.
Department of Dermatology, Fukushima Medical University, Fukushima, Japan.
Takahisa
T
Shiraishi
Toshiyuki
T
Yamamoto
D002675:Child, Preschool; D011146:Eczema, Dyshidrotic / Q000139:chemically induced* / Q000276:immunology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000009:adverse effects*; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000276:immunology* / Q000628:therapy*; D012720:Severity of Illness Index
D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors